摘要2014年3月3日，美国心脏协会（American Heart Association，AHA）和美国心脏病学院（American College of Cardiology，ACC）发布了《2014心脏瓣膜病患者管理指南》（以下简称“指南”）[1]。这是该指南2008年版的更新，有以下几个方面值得我国心脏外科医师重视。
1Nishimura R A, Otto C M, Bonow R 〇,et al. 2014 AHA/ACCGuideline for the Management of Patients With Valvular Heart Dis-ease:A Report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Cuidelines [EB/OL]. JAm Coll Cardiol, (2014-03-03) [2014-04-02].http ://conlenL on-linejacc.org/article. aspx. articleid=1854230&esultClick=3. 被引量：1
3CUNNINGHAM S M.RUSH J E,FREEMAN L M.Short-lerm effecls of alorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease[J].Journal of Veterinary Internal Medicine,2013,27(4):985-989.doi:10.1111/jvim.12123.Epub 2013 Jun 12. 被引量：1
4HAGGSTROM J,LORD PF,HOGLUND K.et al.Short-term hemodynamic and neuroendocrine effecls of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure[J].doi:10.1111/jvim.12123.Epub 2013 Jun 12. 被引量：1
5PATEL S M,OHORI N P,BADHWAR V,et al.From headache to heartache:Ergotamine-induced aortic and mitral valvulopathy[J].J Am Coll Cardio12144.doi:10.1016/j.jacc,2013,62(22):065. 被引量：1
6AISSAOUI N,MORSHUIS M,PALUSZKIEWICZ L A,et al.Comparison of biventricular and left ventricular assist devices for the management of severe right ventricular dysfunction in patients with EndStage heart failure.[J].ASAIO Journal,2014,60(4):400-406.doi:10.1097/MAT.0000000000000082. 被引量：1
7CAO W W,CHEN J W,CHEN Y F,et al.Advanced glycation end products promote heart failure through inducing the immune maturation of dendritic cells[J].Appl Biochem Biotechnol,2014,172(8):40624077.doi:10.1007/s12010-014-0804-7.Epub 2014 Mar 8. 被引量：1
